BUPRENORPHINE ADHERENCE TRAJECTORIES, PERSISTENCE, AND HEALTHCARE EXPENDITURES AMONG COMMERCIALLY INSURED PATIENTS WITH OPIOID USE DISORDER

被引：0
|
作者：
Olateju, O. [1 ]
Thornton, J. D. [2 ]
机构：
[1] Univ Houston, Houston, TX USA
[2] Univ Houston, Coll Pharm, Houston, TX USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR149
引用
收藏
页码：S323 / S324
页数：2
相关论文
共 50 条
  • [31] Mortality Among Patients Prescribed Buprenorphine for Opioid Use Disorder After Disenrollment from an Insurance Plan and Healthcare System
    Nguyen, Anh P.
    Glanz, Jason M.
    Shoup, Jo Ann
    Campbell, Cynthia, I
    Clarke, Christina L.
    Ford, Morgan A.
    Binswanger, Ingrid A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (11) : 2882 - 2884
  • [32] Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder
    Tabatabaeepour, Nadia
    Morgan, Jake R.
    Jalali, Ali
    Kapadia, Shashi N.
    Meinhofer, Angelica
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 140
  • [33] Adherence to buprenorphine treatment guidelines among individuals with an opioid use disorder who have private insurance
    Mark, Tami L.
    Hinde, Jesse M.
    Zarkin, Gary A.
    Parish, William
    Kluckman, Marianne
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 116
  • [34] Patterns of initiation and discontinuation of medications for opioid use disorder in commercially insured individuals in the US
    Seamans, Marissa J.
    Raman, Sudha R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 400 - 400
  • [35] Using buprenorphine to treat patients with opioid use disorder
    Radi, Joshua K.
    Fogarty, Kieran J.
    Lagerwey, Mary D.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (10): : 30 - 35
  • [36] Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder
    Hayes, Corey J.
    Martin, Bradley C.
    Hoggatt, Katherine J.
    Cucciare, Michael A.
    Hudson, Teresa J.
    Gordon, Adam J.
    SUBSTANCE USE & ADDICTION JOURNAL, 2024,
  • [37] Successful engagement in buprenorphine treatment among hospitalized patients with opioid use disorder and trauma
    Bhatraju, Elenore P.
    Ludwig-Barron, Natasha
    Takagi-Stewart, Julian
    Sandhu, Harveen K.
    Klein, Jared W.
    Tsui, Judith, I
    DRUG AND ALCOHOL DEPENDENCE, 2020, 215
  • [38] Prevalence of Nonopioid and Opioid Prescriptions Among Commercially Insured Patients with Chronic Pain
    Miller, Gabrielle F.
    Guy, Gery P.
    Zhang, Kun
    Mikosz, Christina A.
    Xu, Likang
    PAIN MEDICINE, 2019, 20 (10) : 1948 - 1954
  • [39] Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl
    Chambers, Laura C.
    Hallowell, Benjamin D.
    Zullo, Andrew R.
    Paiva, Taylor J.
    Berk, Justin
    Gaither, Rachel
    Hampson, Aidan J.
    Beaudoin, Francesca L.
    Wightman, Rachel S.
    JAMA NETWORK OPEN, 2023, 6 (09) : e2334540
  • [40] Adherence to hormonal therapy among commercially insured breast cancer patients.
    Zhao, Hui
    Lei, Xiudong
    Chavez-MacGregor, Mariana
    He, Weiguo
    Niu, Jiangong
    Giordano, Sharon Hermes
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345